These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alternative pathway dysfunction in kidney disease: a case report and review of dense deposit disease and C3 glomerulopathy. Hawfield A, Iskandar SS, Smith RJ. Am J Kidney Dis; 2013 May; 61(5):828-31. PubMed ID: 23391537 [Abstract] [Full Text] [Related]
5. Retinal disease in the C3 glomerulopathies and the risk of impaired vision. Savige J, Amos L, Ierino F, Mack HG, Symons RC, Hughes P, Nicholls K, Colville D. Ophthalmic Genet; 2016 Dec; 37(4):369-376. PubMed ID: 26915021 [Abstract] [Full Text] [Related]
6. von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study. Chen YY, Han SS, Cao Y, Yu XJ, Zhu L, Luo JC, Song WC, Yu F, Mao YH, Zhao MH. Clin Immunol; 2021 Aug; 229():108794. PubMed ID: 34245915 [Abstract] [Full Text] [Related]
20. Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency. Ruseva MM, Vernon KA, Lesher AM, Schwaeble WJ, Ali YM, Botto M, Cook T, Song W, Stover CM, Pickering MC. J Am Soc Nephrol; 2013 Jan; 24(1):43-52. PubMed ID: 23184055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]